MiniMed™ 770G System Insulin Pump Technology

Self-adjusting technology approved for ages 2 and older.* Now with smartphone connectivity.

LEARN MORE

Overview

 

The new MiniMed™ 770G system automatically adjusts insulin levels and takes on more of the tasks of managing diabetes so your patients can focus more on their daily life.*

  • PREDICTS: Monitors sugars 24/7 and predicts highs and lows in advance.

  • ADAPTS: Continuously adapts to insulin needs based on real-time data and personal trends.

  • SELF-ADJUSTS: Smooths out highs and lows, with SmartGuard™ tech that increases or decreases insulin delivery, every five minutes.
*

Refers to SmartGuard™ Auto Mode. Some user interaction required. Individual results may vary.

Icon with arrow facing up.

Upgradable software

The MiniMed™ 770G system is enabled for future software upgrades, when such software upgrades are available. Customers will be offered a software upgrade at no charge through December 2021.

MinimeD™ 770G System overview

TO HELP KEEP YOUR PATIENTS IN SAFE RANGE

The MiniMed 770G system displayed on body with mobile app and Quickset.

1. Insulin Pump

SmartGuard™ Auto Mode automatically adjusts insulin delivery.* It helps predict highs and lows in advance and increases or decreases insulin delivery. Now with smartphone connectivity.

2. Infusion Set 

Allows for continuous and discreet delivery of insulin through a thin, flexible tube.

3. Continuous Glucose Monitor (CGM)

The Guardian™ Sensor 3 measures sugar levels every 5 minutes and automatically sends information to the pump.

4. Smartphone Apps

The MiniMed™ Mobile app provides discretion and convenience for the patient. The CareLink™ Connect app allows up to five care partners to see insulin, pump and CGM data.

*

Refers to SmartGuard™ Auto Mode. Some user interaction required. Individual results may vary.

Automatic CareLink™ data uploads

ENABLING MEANINGFUL PATIENT CONVERSATIONS

The MiniMed™ 770G system with Bluetooth® connectivity enables automatic CareLink™ uploads, helping support meaningful conversations with your patients, whether in-person or via telehealth.

NO MORE LAST-MINUTE PUMP UPLOADS

CONVENIENT

  • Your patients’ data can now be easily uploaded prior to their appointments.

ACTIONABLE

  • Providing access to insights for your patients’ therapy adjustments.

AVAILABLE 24/7

  • Giving you and your patients the ability to view data whenever needed.

 

HELPING PATIENTS & CARE PARTNERS FOCUS ON THEIR LIFE, NOT THEIR LEVELS

Smartphone Connectivity Enables New Features

The MiniMed™ Mobile app and CareLink™ Connect app help your patients and their families live more and worry less. 

 

 

MINIMED™ MOBILE APP

Your patients can now use their smartphones to view their data. This means they can easily and discreetly track their glucose levels and get notified of highs and lows.

 

 

carelink™ connect APP

Available for care partners, this app helps keep everyone in the loop. Up to five care partners can now follow a pump user and receive high and low notifications.

 

 

SmartGuard™ Auto Mode

Automatically Adjusts Insulin Levels Every 5 Minutes

Each day and night, insulin needs vary.

By constantly adapting to real-time glucose needs, SmartGuard™ technology automatically adjust basal insulin to help keep your patients in target glucose range.*

A graph showing night 1 on the 770G system.
A graph showing night 3 on the 770G system.
A graph showing night 2 on the 770G system.
A graph showing night 4 on the 770G system.

CareLinkTM Patient Representative Profile

Expand All

TECHNICAL SPECIFICATIONS

COMPATIBLE PRODUCTS

REQUEST MORE INFORMATION

Complete the form below and a sales representative will follow up with additional information.

* Indicates a required field.

By clicking Submit, I confirm that I have read and agree to the Authorization and permit Medtronic to use my contact information for the purposes described in the authorization. Read More.
*

Refers to SmartGuard™ Auto Mode. Some user interaction required. Individual results may vary.

Program eligibility requirements and terms and conditions apply. Subject to change.

Important Safety Information: MiniMedTM 770G System with SmartGuardTM Technology

The MiniMed™ 770G system is intended for continuous delivery of basal insulin (at user selectable rates) and administration of insulin boluses (in user selectable amounts) for the management of type 1 diabetes mellitus in persons two years of age and older requiring insulin as well as for the continuous monitoring and trending of glucose levels in the fluid under the skin. The MiniMed™ 770G system includes SmartGuard™ technology, which can be programmed to automatically adjust delivery of basal insulin based on continuous glucose monitoring (CGM) sensor glucose (SG) values and can suspend delivery of insulin when the SG value falls below or is predicted to fall below predefined threshold values.

The Medtronic MiniMed™ 770G system consists of the following devices: MiniMed™ 770G insulin pump, the Guardian™ Link (3) transmitter, the Guardian™ Sensor (3), one-press serter, the Accu-Chek® Guide Link blood glucose meter, and the Accu-Chek® Guide test strips. The system requires a prescription.

The Guardian™ Sensor (3) has not been evaluated and is not intended to be used directly for making therapy adjustments, but rather to provide an indication of when a fingerstick may be required. All therapy adjustments should be based on measurements obtained using a blood glucose meter and not on values provided by the Guardian™ Sensor (3).

All therapy adjustments should be based on measurements obtained using the Accu-Chek® Guide Link blood glucose meter and not on values provided by the Guardian™ Sensor (3). Always check the pump display to ensure the glucose result shown agrees with the glucose results shown on the Accu-Chek® Guide Link blood glucose meter. Do not calibrate your CGM device or calculate a bolus using a blood glucose meter result taken from an alternative site. It is not recommended to calibrate your CGM device when sensor or blood glucose values are changing rapidly, e.g., following a meal or physical exercise.

WARNING: Do not use the SmartGuard™ Auto Mode for people who require less than 8 units or more than 250 units of total daily insulin per day. A total daily dose of at least 8 units, but no more than 250 units, is required to operate in SmartGuard™ Auto Mode.

WARNING: Do not use the MiniMed™ 770G system until appropriate training has been received from a healthcare professional. Training is essential to ensure the safe use of the MiniMed™ 770G system.

Pump therapy is not recommended for people whose vision or hearing does not allow recognition of pump signals and alarms. Pump therapy is not recommended for people who are unwilling or unable to maintain contact with their healthcare professional. The safety of the MiniMed™ 770G system has not been studied in pregnant women. For complete details of the system, including product and important safety information such as indications, contraindications, warnings and precautions associated with system and its components, please consult http://www.medtronicdiabetes.com/important-safety-information#minimed-770g and the appropriate user guide at http://www.medtronicdiabetes.com/download-library

The Bluetooth® word mark and logos are registered trademarks owned by Bluetooth SIG, Inc. and any use of such marks by Medtronic is under license.”

©2020 Medtronic. All rights reserved. Medtronic, Medtronic logo and Further, Together are trademarks of Medtronic. Third party brands are trademarks of their respective owners. All other brands are trademarks of a Medtronic company.